Related references
Note: Only part of the references are listed.The Impact of Median Model for End-Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma
Sarah Bernards et al.
LIVER TRANSPLANTATION (2022)
Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma
Anjiya Shaikh et al.
TRANSPLANTATION DIRECT (2022)
Disparities in the Effects of Acuity Circle-based Liver Allocation on Waitlist and Transplant Practice Between Centers
Shunji Nagai et al.
TRANSPLANTATION DIRECT (2022)
Trends in Outcomes for Marginal Allografts in Liver Transplant
Theodore Zhang et al.
JAMA SURGERY (2020)
Projected outcomes of 6-month delay in exception points versus an equivalent Model for End-Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates
Sarah K. Alver et al.
LIVER TRANSPLANTATION (2016)
Characteristics associated with liver graft failure: The concept of a donor risk index
S Feng et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)